Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Devices Books 43-Percent Increase in Revenues, 30 Percent Rise in Earnings in Q1

NEW YORK, April 29 (GenomeWeb News) - Molecular Devices yesterday reported increased revenues and profits for the first quarter of 2005.


Revenues for the quarter were $39.1 million, up year-over-year from $27.3 million. Both the life sciences and drug discovery product areas contributed to the growth.


Research and development costs increased to $6.2 million from $4 million during the year-ago period.


The company's net income for the quarter totaled $2.2 million, or $.13 per share, up from $1.4 million, or $.10 per share, during last year's first quarter.


As of March 31, Molecular Devices had $8.3 million in cash and cash equivalents.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.